RESÚMENES DICIEMBRE 2004

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

(Requiere estar conectado a internet. Haga un click en la información del journal)

 

The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight?

R. Michael Bagby, Andrew G. Ryder, Deborah R. Schuller, and Margarita B. Marshall

Am J Psychiatry 161:2163-2177, December 2004

Impaired GABA Neuronal Response to Acute Benzodiazepine Administration in Panic Disorder

Andrew W. Goddard, Graeme F. Mason, Michael Appel, Douglas L. Rothman, Ralitza Gueorguieva, Kevin L. Behar, and John H. Krystal

Am J Psychiatry 161:2186-2193, December 2004

Enhanced Dopamine Transporter Density in Psychotropic-Naive Patients With Obsessive-Compulsive Disorder Shown by [123I]ß-CIT SPECT

Nic J. van der Wee, Henk Stevens, Johannes A. Hardeman, Rene C. Mandl, Damiaan A. Denys, Harold J. van Megen, René S. Kahn, and Herman M. Westenberg

Am J Psychiatry 161:2201-2206, December 2004

Panic Attack as a Risk Factor for Severe Psychopathology

Renee D. Goodwin, Roselind Lieb, Michael Hoefler, Hildegard Pfister, Antje Bittner, Katja Beesdo, and Hans-Ulrich Wittchen

Am J Psychiatry 161:2207-2214, December 2004

Comorbidity of Anxiety Disorders With Anorexia and Bulimia Nervosa

Walter H. Kaye, Cynthia M. Bulik, Laura Thornton, Nicole Barbarich, Kim Masters, and the Price Foundation Collaborative Group

Am J Psychiatry 161:2215-2221, December 2004

Anxiety Disorder Comorbidity in Bipolar Disorder Patients: Data From the First 500 Participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

Naomi M. Simon, Michael W. Otto, Stephen R. Wisniewski, Mark Fossey, Kemal Sagduyu, Ellen Frank, Gary S. Sachs, Andrew A. Nierenberg, Michael E. Thase, and Mark H. Pollack, for the STEP-BD Investigators

Am J Psychiatry 161:2222-2229, December 2004

A Longitudinal Evaluation of the Relationship Between Reproductive Status and Mood in Perimenopausal Women

Peter J. Schmidt, Nazli Haq, and David R. Rubinow

Am J Psychiatry 161:2238-2244, December 2004

 

Are we going to increase the use of antidepressants up to that of benzodiazepines?

Arcangelo Ciuna, Margherita Andretta, Letizia Corbari, Deborah Levi, Mersia Mirandola, Adriano Sorio and Corrado Barbui 

European Journal of Clinical Pharmacology 2004;  Volume 60, Number 9: 629 - 634

 

Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol

Anatoly B. Smulevich, Sumant Khanna, Mariëlle Eerdekens, Keith Karcher, Michelle Kramer and Fred Grossman

European Neuropsychopharmacology. Volume 15, Issue 1, January 2005, Pages 75-84

 

Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania

Robert W. Baker, Eileen Brown, Hagop S. Akiskal, Joseph R. Calabrese, Terence A. Ketter, Leslie M. Schuh, Paula T. Trzepacz, John G. Watkin, Mauricio Tohen

The British Journal of Psychiatry (2004) 185: 472-478

Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D

William R. Yates, Jeff Mitchell, A. John Rush, Madhukar H. Trivedi, Stephen R. Wisniewski, Diane Warden, Robert B. Hauger, Maurizio Fava, Bradley N. Gaynes, Mustafa M. Husain and Charlene Bryan

General Hospital Psychiatry. Volume 26, Issue 6, November-December 2004, Pages 421-429

 

Depression and diabetes symptom burden

Evette J. Ludman, Wayne Katon, Joan Russo, Michael Von Korff, Gregory Simon, Paul Ciechanowski, Elizabeth Lin, Terry Bush, Edward Walker and Bessie Young

General Hospital Psychiatry. Volume 26, Issue 6, November-December 2004, Pages 430-436

 

The prognosis of minor depression in the general population: a systematic review

Marleen L.M. Hermens, Hein P.J. van Hout, Berend Terluin, Daniëlle A.W.M. van der Windt, Aartjan T.F. Beekman, Richard van Dyck and Marten de Haan

General Hospital Psychiatry. Volume 26, Issue 6, November-December 2004, Pages 453-462

 

Neurobiology and pharmacotherapy of social phobia
Aouizerate B, Martin-Guehl C, Tignol J

Encephale. 2004 Sep-Oct;30(1):301-13

 

Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients

Annique Schins, Karly Hamulyák, Simon Scharpé, Richel Lousberg, Joost Van Melle, Harry Crijns and Adriaan Honig

Life Sciences. Volume 76, Issue 6, 24 December 2004, Pages 637-650

 

Hippocampal changes and white matter lesions in early-onset depression

Joost Janssen, Hilleke E. Hulshoff Pol, Indrag K. Lampe, Hugo G. Schnack, Frank-Erik de Leeuw, Rene S. Kahn and Thea J. Heeren

Biological Psychiatry. Volume 56, Issue 11, 1 December 2004, Pages 825-831

 

The effect of successful treatment on the emotional and physiological response to carbon dioxide inhalation in patients with panic disorder

Jack M. Gorman, Jose Martinez, Jeremy D. Coplan, Justine Kent and Marc Kleber

Biological Psychiatry. Volume 56, Issue 11, 1 December 2004, Pages 862-867

 

 

Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression

Andrew F. Leuchter, Melinda Morgan, Ian A. Cook, Jennifer Dunkin, Michelle Abrams and Elise Witte

Psychopharmacology 2004; Volume 177, Numbers 1-2: 15 - 22

 

Agitated depression: a valid depression subtype?

Franco Benazzi

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 28, Issue 8, December 2004, Pages 1279-1285

 

The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder

Koen Schruers, Eric Griez

Journal of Psychopharmacology, Vol. 18, No. 4, 553-558 (2004)

Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects

Elio Ciusani, Daniele F. Zullino, Chin B. Eap, Marlyse Brawand-Amey, Murielle Brocard, Pierre Baumann

Journal of Psychopharmacology, Vol. 18, No. 4, 559-566 (2004)

Metyrapone as Additive Treatment in Major Depression. A Double-blind and Placebo-Controlled Trial

Holger Jahn, Mildred Schick, Falk Kiefer, Michael Kellner, Alexander Yassouridis, Klaus Wiedemann

Arch Gen Psychiatry. 2004;61:1235-1244

 

Brain Serotonin Transporter Binding Potential Measured With Carbon 11–Labeled DASB Positron Emission Tomography. Effects of Major Depressive Episodes and Severity of Dysfunctional Attitudes

Jeffrey H. Meyer, Sylvain Houle, Sandra Sagrati, Anna Carella, F. Hussey, Nathalie Ginovart, Verdell Goulding, James Kennedy, Alan A. Wilson

Arch Gen Psychiatry. 2004;61:1271-1279

 

Hypericum extract LI 160 and fluoxetine in mild to moderate depressionA randomized, placebo-controlled multi-center study in outpatients.
Bjerkenstedt L, Edman GV, Alken RG, Mannel M.

Eur Arch Psychiatry Clin Neurosci. 2004 Nov 12; [Epub ahead of print]

 

Factors that differentiate early vs. later onset of major depression disorder

Sidney Zisook, A. John Rush, Ari Albala, Jonathan Alpert, G.K. Balasubramani, Maurizio Fava, Mustafa Husain, Harold Sackeim, Madhukar Trivedi and Stephen Wisniewski

Psychiatry Research. Volume 129, Issue 2, 15 December 2004, Pages 127-140


Evidence-based pharmacotherapy of Generalized Anxiety Disorder.

Baldwin DS, Polkinghorn C

Int J Neuropsychopharmacol. 2004 Dec 3;:1-10 [Epub ahead of print]

 

Geriatric Depression Treatment in Nonresponders to Selective Serotonin Reuptake Inhibitors

Ellen M. Whyte, James Basinski, Panthea Farhi, Mary Amanda Dew, Amy Begley, Benoit H. Mulsant, and Charles F. Reynolds III.

J Clin Psychiatry 2004;65:1634-1641

 

Cerebrovascular Effects of Selective Serotonin Reuptake Inhibitors: A Systematic Review

Rajamannar Ramasubbu

J Clin Psychiatry 2004;65:1642-1653

 

An Open Trial of Topiramate in the Treatment of Generalized Social Phobia

Michael Van Ameringen, Catherine Mancini, Beth Pipe, Jonathan Oakman, and Mark Bennett

J Clin Psychiatry 2004;65:1674-1678

 

Weight Gain During Treatment of Bipolar I Patients With Olanzapine

John Hennen, Roy H. Perlis, Sachs, Mauricio Tohen, and Ross J. Baldessarini

J Clin Psychiatry 2004;65:1679-1687

 

Remission Rates in Patients With Anxiety Disorders Treated With Paroxetine

James C. Ballenger

J Clin Psychiatry 2004;65:1696-1707

 

Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials

Arif Khan, Amy E. Brodhead, Russell L. Kolts and Walter A. Brown

Journal of Psychiatric Research. Volume 39, Issue 2, March 2005, Pages 145-150

 

Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies

Stephen K. Brannan, Craig H. Mallinckrodt, Michael J. Detke, John G. Watkin and Gary D. Tollefson

Journal of Psychiatric Research. Volume 39, Issue 2, March 2005, Pages 161-172

 

Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction

Eija Airaksinen, Maria Larsson and Yvonne Forsell

Journal of Psychiatric Research. Volume 39, Issue 2, March 2005, Pages 207-214

 

Neuroplasticity: from MRI to depressive symptoms

Philippe Fossati, Andrei Radtchenko and Patrice Boyer

European Neuropsychopharmacology. Volume 14, Supplement 5, December 2004, Pages S503-S510

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

Michael J. Detke, Curtis G. Wiltse, Craig H. Mallinckrodt, Robert K. McNamara, Mark A. Demitrack and Istvan Bitter

European Neuropsychopharmacology. Volume 14, Issue 6, December 2004, Pages 457-470

Differences in beta-adrenergic receptor sensitivity between women and men with panic disorder

Youl-Ri Kim, Sung Kil Min and Bum-Hee Yu

European Neuropsychopharmacology. Volume 14, Issue 6, December 2004, Pages 515-520

 

Medication management of depression. The impact of comorbid chronic medical conditions

Paul A. Kurdyak and William H. Gnam

Journal of Psychosomatic Research. Volume 57, Issue 6, December 2004, Pages 565-571

 

Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates

Christine Lochner, Sian M.J. Hemmings, Craig J. Kinnear, Dana J.H. Niehaus, Daniel G. Nel, Valerie A. Corfield, Johanna C. Moolman-Smook, Soraya Seedat and Dan J. Stein

Comprehensive Psychiatry. Volume 46, Issue 1, January-February 2005, Pages 14-19

 

A population-based study of anxiety as a precursor for depression in childhood and adolescence
Frances Rice, Marianne B.M van den Bree and Anita Thapar
BMC Psychiatry 2004, 4:43; 13 December 2004

 

Males and females respond differently to controllability and antidepressant treatment

Benedetta Leuner, Sabrina Mendolia-Loffredo and Tracey J. Shors

Biological Psychiatry. Volume 56, Issue 12, 15 December 2004, Pages 964-970

 

Mood state at study entry as predictor of the polarity of relapse in bipolar disorder

Joseph R. Calabrese, Eduard Vieta, Rif El-Mallakh, Robert L. Findling, Eric A. Youngstrom, Omar Elhaj, Prashant Gajwani and Ronald Pies

Biological Psychiatry. Volume 56, Issue 12, 15 December 2004, Pages 957-963

 

Reduced brain serotonin transporter binding in patients with panic disorder

Eduard Maron, Jyrki T. Kuikka, Jakov Shlik, Veiko Vasar, Esko Vanninen and Jari Tiihonen

Psychiatry Research: Neuroimaging. Volume 132, Issue 2, 15 December 2004, Pages 173-181

 

Gender differences in routine treatment of depressed outpatients with the selective serotonin reuptake inhibitor sertraline.
Thiels, Cornelia; Linden, Michael; Grieger, Frank; Leonard, Joachim

International Clinical Psychopharmacology. 20(1):1-7, January 2005.

Association of Serotonin 5-HT2A Receptor Binding and the T102C Polymorphism in Depressed and Healthy Caucasian Subjects
Vadim D Khait, Yung-yu Huang, Gil Zalsman, Maria A Oquendo, David A Brent, Jill M Harkavy-Friedman and J John Mann

Neuropsychopharmacology (2005) 30, 166-172

 

Joint symptoms in patients on bupropion therapy.
Ornetti P, Disson-Dautriche A, Muller G, Cherasse A, Tavernier C, Besancenot JF, Sgro C, Maillefert JF

Joint Bone Spine. 2004 Nov;71(6):583-5

 

Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study

Won-Myong Bahk, Young-Chul Shin, Jong-Min Woo, Bo-Hyun Yoon, Jung-Seo Lee, Duk-In Jon, Sang-Keun Chung, Sung-Ku Choi, In-Ho Paik and Chi-Un Pae

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 29, Issue 1, January 2005, Pages 115-121

 

Acute psychosis following sustained release bupropion overdose

Tzong-Shi Wang, I-Shin Shiah, Chin-Bin Yeh and Chuan-Chia Chang

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 29, Issue 1, January 2005, Pages 149-151

 

The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression

Boghos I. Yerevanian, Jamie D. Feusner, Ralph J. Koek and Jim Mintz

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 103-108

 

Electroconvulsive therapy in depressive illness that has not responded to drug treatment

Syed S. Husain, Ian Mark Kevan, Rebecca Linnell and Allan I.F. Scott

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 121-126

 

Prevalence and risk indicators of depression in elderly nursing home patients: the AGED study

K. Jongenelis, A.M. Pot, A.M.H. Eisses, A.T.F. Beekman, H. Kluiter and M.W. Ribbe

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 135-142

 

Depression in older persons with versus without vascular disease in the open population: similar depressive symptom patterns, more disability

Els Licht-Strunk, Marijke A. Bremmer, Harm W.J. van Marwijk, Dorly J.H. Deeg, Witte J.G. Hoogendijk, Marten de Haan, Willem van Tilburg and Aartjan T.F. Beekman

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 155-160

 

Ethnic differences in first clinical presentation of bipolar disorder: results from an epidemiological study

N. Kennedy, J. Boydell, J. van Os and R.M. Murray

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 161-168

 

Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study

Michael Bauer, Lynn Fairbanks, Anne Berghöfer, Johannes Hierholzer, Tom Bschor, Christopher Baethge, Natalie Rasgon, Johanna Sasse and Peter C. Whybrow

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 183-190

 

The relationship between duration of labour, time of delivery, and puerperal psychosis

Verinder Sharma, Angela Smith and Mustaq Khan

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 215-220

 

Temperament and depressive symptoms: a population-based longitudinal study on Cloninger's psychobiological temperament model

Marko Elovainio, Mika Kivimäki, Sampsa Puttonen, Tarja Heponiemi, Laura Pulkki and Liisa Keltikangas-Järvinen

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 227-232

 

A comparative study of milnacipran and paroxetine in outpatients with major depression

Daniel Sechter, Pierre Vandel, Emmanuel Weiller, Nicole Pezous, Fabienne Cabanac, Alain Tournoux and the study co-coordinators

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 233-236

 

Depression with atypical features in a sample of primary care outpatients: prevalence, specific characteristics and consequences

Verena Henkel, Roland Mergl, James C. Coyne, Ralf Kohnen, Antje-Kathrin Allgaier, Elke Rühl, Hans-Jürgen Möller and Ulrich Hegerl

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 237-242

 

Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder

Robert Lasser, Cynthia A. Bossie, Georges Gharabawi, Marielle Eerdekens and Henry A. Nasrallah

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 263-275

 

Effects of clozapine on sleep in bipolar and schizoaffective disorders

Roseanne Armitage, Darwynn Cole, Trisha Suppes and Mehmet E. Ozcan

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 28, Issue 7, November 2004, Pages 1065-1070

 

 

Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial

Murray B. Stein, Mark H. Pollack, Alexander Bystritsky, Jeffrey E. Kelsey and Richard M. Mangano

Psychopharmacology 2005;Volume 177, Number 3: 280 - 288

 

 

Metamemory without the memory: are people aware of midazolam-induced amnesia?

Paul Merritt, Elliot Hirshman, John Hsu and Michael Berrigan

Psychopharmacology 2005;Volume 177, Number 3: 336 - 343

 

The effect of midazolam on visual search: Implications for understanding amnesia

Heekyeong Park, Joseph Quinlan, Edward Thornton and Lynne M. Reder 

PNAS | December 21, 2004 | vol. 101 | no. 51 | 17879-17883

The Role of Venlafaxine in the Treatment of Obsessive–Compulsive Disorder

Nicole J Phelps, Marshall E Cates

The Annals of Pharmacotherapy: Vol. 39, No. 1, pp. 136-140

Use of Selective Serotonin-Reuptake Inhibitors in the Treatment of Depression in Adults with HIV

Joshua Caballero, Milap C Nahata

The Annals of Pharmacotherapy: Vol. 39, No. 1, pp. 141-145

 

Is apathy in late-life depressive illness related to age-at-onset, cognitive function or vascular risk?

Indrag K. Lampe and Thea J. Heeren 

International Psychogeriatrics (2004), 16:4:481-486

 

Training Latin American primary care physicians in the WPA module on depression: results of a multicenter trial

ITZHAK LEVAV, ROBERT KOHN, IVAN MONTOYA, CARLOS PALACIO, PABLO ROZIC, IDA SOLANO, WILLIANS VALENTINI, BENJAMIN VICENTE, JORGE CASTRO MORALES, FRANCISCO ESPEJO EIGUETA, YAMINI SARAVANAN, CLAUDIO T. MIRANDA and NORMAN SARTORIUS 

Psychological Medicine (2005), 35:1:35-45

 

Dose–effect relations in time-limited combined psycho-pharmacological treatment for depression

J. DEKKER, P. J. MOLENAAR, S. KOOL, G. VAN AALST, J. PEEN and F. de JONGHE 

Psychological Medicine (2005), 35:1:47-58

 

The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression

NATHAN A. GILLESPIE, JOHN B. WHITFIELD, BEN WILLIAMS, ANDREW C. HEATH and NICHOLAS G. MARTIN

Psychological Medicine (2005), 35:1:101-111

 

Association between mortality from suicide in England and antidepressant prescribing: an ecological study
Oliver WC Morgan, Clare Griffiths and Azeem Majeed
BMC Public Health 2004, 4:63; 21 December 2004

.

Regresar a RESÚMENES DICIEMBRE 2004